IFORMULATE

Serial Number 90713374
Registration 6743350
700

Registration Progress

Application Filed
May 15, 2021
Under Examination
Approved for Publication
Mar 15, 2022
Published for Opposition
Mar 15, 2022
Registered
May 31, 2022

Trademark Image

IFORMULATE

Basic Information

Serial Number
90713374
Registration Number
6743350
Filing Date
May 15, 2021
Registration Date
May 31, 2022
Published for Opposition
March 15, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 31, 2022
Registration
Registered
Classes
001 042

Rights Holder

HTD Biosystems, Inc.

03
Address
1061 Serpentine Ln., Suite E
Pleasanton, CA 94566

Ownership History

HTD Biosystems, Inc.

Original Applicant
03
Pleasanton, CA

HTD Biosystems, Inc.

Owner at Publication
03
Pleasanton, CA

HTD Biosystems, Inc.

Original Registrant
03
Pleasanton, CA

Legal Representation

Attorney
Micah Drayton

USPTO Deadlines

Next Deadline
880 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220531)
Due Date
May 31, 2028
Grace Period Ends
November 30, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description Documents
Apr 20, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 20, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 20, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 20, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 31, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 31, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 23, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 10, 2022 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 8, 2022 ALIE A ASSIGNED TO LIE Loading...
Feb 4, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 31, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 31, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 31, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 31, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 25, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 13, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 19, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (ADCs), all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of pH, ionic strength, buffer and stability concentrations, all the foregoing using Design of Experiments Approach in a multivariate fashion
First Use Anywhere: Jun 28, 2010
First Use in Commerce: Jun 28, 2010
Class 042
Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy
First Use Anywhere: Mar 28, 2010
First Use in Commerce: Jun 28, 2010

Additional Information

Pseudo Mark
I FORMULATE

Classification

International Classes
001 042